We have previously reported N-(methoxycarbonyl)aporphinoid
alkaloids such as romucosine to have significant
antiplatelet aggregation activity.18,24 It appears that these
aporphine alkaloids act by a different mechanism from that
of aspirin, which is known to be a cyclooxygenase inhibitor.
18 The antiplatelet aggregation activity of these compounds
needs to be further investigated.